{"transactions":[{"id":310133,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-04T20:36:45.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":4884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026."}],"balance_after":4884,"derivative":{"exercise_price":130.84,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":4884},"source":{"system":"sec-edgar","filing":"0001183680-26-000002","document":"wk-form4_1777927002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000118368026000002/wk-form4_1777927002.xml","form_type":"4"}},{"id":310132,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T20:36:45.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":1146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 1,146 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026."}],"balance_after":27202,"source":{"system":"sec-edgar","filing":"0001183680-26-000002","document":"wk-form4_1777927002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000118368026000002/wk-form4_1777927002.xml","form_type":"4"}},{"id":322409,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-08T22:20:17.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":6809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025."}],"balance_after":6809,"derivative":{"exercise_price":98.9,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":6809},"source":{"system":"sec-edgar","filing":"0001127602-25-013745","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225013745/form4.xml","form_type":"4"}},{"id":322408,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-08T22:20:17.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":1516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 1,516 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 7, 2025."}],"balance_after":26056,"source":{"system":"sec-edgar","filing":"0001127602-25-013745","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225013745/form4.xml","form_type":"4"}},{"id":333985,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-05-09T21:57:24.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":12648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024."}],"balance_after":12648,"derivative":{"exercise_price":64.92,"expiration_date":"2034-05-08","underlying":"Common Stock","underlying_shares":12648},"source":{"system":"sec-edgar","filing":"0001127602-24-014834","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224014834/form4.xml","form_type":"4"}},{"id":333984,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-09T21:57:24.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":2310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 2,310 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 8, 2024."}],"balance_after":24540,"source":{"system":"sec-edgar","filing":"0001127602-24-014834","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224014834/form4.xml","form_type":"4"}},{"id":349444,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-05-04T23:10:57.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":10173,"price":79.45,"value":808244.85,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023."}],"balance_after":10173,"derivative":{"exercise_price":79.45,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":10173},"source":{"system":"sec-edgar","filing":"0001127602-23-014593","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223014593/form4.xml","form_type":"4"}},{"id":349443,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-04T23:10:57.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":1887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 1,887 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023."}],"balance_after":22230,"source":{"system":"sec-edgar","filing":"0001127602-23-014593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223014593/form4.xml","form_type":"4"}},{"id":361729,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-05-06T23:04:24.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":15851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately on the grant date of May 5, 2022."}],"balance_after":15851,"derivative":{"exercise_price":61.35,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":15851},"source":{"system":"sec-edgar","filing":"0001127602-22-013728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013728/form4.xml","form_type":"4"}},{"id":361728,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-06T23:04:24.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":2444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 2,444 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.  The RSUs vested immediately upon the grant date of May 5, 2022."}],"balance_after":20343,"source":{"system":"sec-edgar","filing":"0001127602-22-013728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013728/form4.xml","form_type":"4"}},{"id":361941,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-05-04T00:21:22.000Z","date":"2022-05-03","kind":"exercise","acquired":false,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested on May 3, 2022."}],"balance_after":4553,"derivative":{"underlying":"Common Stock","underlying_shares":2223},"source":{"system":"sec-edgar","filing":"0001127602-22-013133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013133/form4.xml","form_type":"4"}},{"id":361940,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-04T00:21:22.000Z","date":"2022-05-03","kind":"exercise","acquired":true,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":17899,"source":{"system":"sec-edgar","filing":"0001127602-22-013133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013133/form4.xml","form_type":"4"}},{"id":375563,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-05-14T20:27:17.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":14665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":14665,"derivative":{"exercise_price":67.45,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":14665},"source":{"system":"sec-edgar","filing":"0001127602-21-016858","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221016858/form4.xml","form_type":"4"}},{"id":375562,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-05-14T20:27:17.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":6776,"derivative":{"underlying":"Common Stock","underlying_shares":2223},"source":{"system":"sec-edgar","filing":"0001127602-21-016858","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221016858/form4.xml","form_type":"4"}},{"id":375877,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-05-07T22:59:56.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":1936,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested on May 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested on May 6, 2021."}],"balance_after":4553,"derivative":{"underlying":"Common Stock","underlying_shares":1936},"source":{"system":"sec-edgar","filing":"0001127602-21-015954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221015954/form4.xml","form_type":"4"}},{"id":375876,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-07T22:59:56.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":1936,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":15676,"source":{"system":"sec-edgar","filing":"0001127602-21-015954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221015954/form4.xml","form_type":"4"}},{"id":391045,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-05-08T00:08:55.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":7886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on each three-month anniversary from May 6, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":7886,"derivative":{"exercise_price":77.47,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":7886},"source":{"system":"sec-edgar","filing":"0001127602-20-015835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015835/form4.xml","form_type":"4"}},{"id":391044,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2020-05-08T00:08:55.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":1936,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units will vest upon the earlier of May 6, 2021, or the day immediately preceding the next regular annual stockholders meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units will vest upon the earlier of May 6, 2021, or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":6489,"derivative":{"underlying":"Common Stock","underlying_shares":1936},"source":{"system":"sec-edgar","filing":"0001127602-20-015835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015835/form4.xml","form_type":"4"}},{"id":3178038,"issuer":{"id":3233,"kind":"organization","name":"DOW INC."},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-13T21:19:40.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":5061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Time vested restricted stock units to be settled in one installment of shares of common stock of the Issuer following the date of separation of the Reporting Person."}],"balance_after":25158,"source":{"system":"sec-edgar","filing":"0001225208-20-006414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751788/000122520820006414/doc4.xml","form_type":"4"}},{"id":403306,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2019-05-10T21:40:30.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":2270,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":4553,"derivative":{"underlying":"Common Stock","underlying_shares":2270},"source":{"system":"sec-edgar","filing":"0001127602-19-018192","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219018192/form4.xml","form_type":"4"}},{"id":403305,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-05-10T21:40:30.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":11848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on each three-month anniversary from May 8, 2019 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 8, 2020 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":11848,"derivative":{"exercise_price":66.07,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":11848},"source":{"system":"sec-edgar","filing":"0001127602-19-018192","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219018192/form4.xml","form_type":"4"}},{"id":3555994,"issuer":{"id":3233,"kind":"organization","name":"DOW INC."},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-04-15T21:08:55.000Z","date":"2019-04-01","kind":"other","acquired":true,"shares":627,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 1, 2019, the Issuer separated from DowDuPont Inc. by issuing a dividend of the Issuer's common stock as further described in the Information Statement filed as Exhibit 99.1 to Form 10 filed by the Issuer on March 8, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being filed solely to reflect an additional 427 shares of Common Stock, which were inadvertently omitted from the Form 4 of the Reporting Person filed with the Securities and Exchange Commission on April 3, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Total includes one share of common stock of the Issuer received for every three shares of DowDuPont common stock in connection with the separation."}],"balance_after":627,"source":{"system":"sec-edgar","filing":"0001225208-19-006764","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751788/000122520819006764/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3555888,"issuer":{"id":3233,"kind":"organization","name":"DOW INC."},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-04-15T21:08:07.000Z","date":"2019-04-11","kind":"grant","acquired":true,"shares":3380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Time vested restricted stock units to be settled in one installment of shares of common stock of the Issuer following the date of separation of the Reporting Person."}],"balance_after":20097,"source":{"system":"sec-edgar","filing":"0001225208-19-006752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751788/000122520819006752/doc4.xml","form_type":"4"}},{"id":3565309,"issuer":{"id":3233,"kind":"organization","name":"DOW INC."},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2019-04-04T01:49:33.000Z","date":"2019-04-01","kind":"other","acquired":true,"shares":1616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"There is generally no conversion price for these phantom stock units. Each phantom stock unit is the equivalent of one share of common stock of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 1, 2019, the Issuer separated from DowDuPont Inc. by issuing a dividend of the Issuer's common stock as further described in the Information Statement filed as Exhibit 99.1 to Form 10 filed by the Issuer on March 8, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Phantom stock units accrue under a compensation deferral election. Phantom stock units are payable in cash in lump sum or installments at the election of the Reporting Person, and do not carry an exercisable date or expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Phantom stock units accrue under a compensation deferral election. Phantom stock units are payable in cash in lump sum or installments at the election of the Reporting Person, and do not carry an exercisable date or expiration date."}],"balance_after":1616,"derivative":{"underlying":"Common Stock","underlying_shares":1616},"source":{"system":"sec-edgar","filing":"0001225208-19-006417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751788/000122520819006417/doc4.xml","form_type":"4"}},{"id":3565308,"issuer":{"id":3233,"kind":"organization","name":"DOW INC."},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-04-04T01:49:33.000Z","date":"2019-04-01","kind":"other","acquired":true,"shares":200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 1, 2019, the Issuer separated from DowDuPont Inc. by issuing a dividend of the Issuer's common stock as further described in the Information Statement filed as Exhibit 99.1 to Form 10 filed by the Issuer on March 8, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes one share of common stock of the Issuer received for every three shares of DowDuPont common stock in connection with the separation."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001225208-19-006417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751788/000122520819006417/doc4.xml","form_type":"4"}},{"id":3565307,"issuer":{"id":3233,"kind":"organization","name":"DOW INC."},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-04-04T01:49:33.000Z","date":"2019-04-01","kind":"other","acquired":true,"shares":16717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 1, 2019, the Issuer separated from DowDuPont Inc. by issuing a dividend of the Issuer's common stock as further described in the Information Statement filed as Exhibit 99.1 to Form 10 filed by the Issuer on March 8, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes one share of common stock of the Issuer received for every three shares of DowDuPont common stock in connection with the separation."}],"balance_after":16717,"source":{"system":"sec-edgar","filing":"0001225208-19-006417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751788/000122520819006417/doc4.xml","form_type":"4"}},{"id":408628,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2019-02-01T23:10:41.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":480,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested on January 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested on January 31, 2019."}],"balance_after":2283,"derivative":{"underlying":"Common Stock","underlying_shares":480},"source":{"system":"sec-edgar","filing":"0001127602-19-003501","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219003501/form4.xml","form_type":"4"}},{"id":408627,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-01T23:10:41.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":480,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":13740,"source":{"system":"sec-edgar","filing":"0001127602-19-003501","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219003501/form4.xml","form_type":"4"}},{"id":415046,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2018-05-11T23:05:51.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2283,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":2763,"derivative":{"underlying":"Common Stock","underlying_shares":2283},"source":{"system":"sec-edgar","filing":"0001127602-18-017238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218017238/form4.xml","form_type":"4"}},{"id":415045,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-05-11T23:05:51.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":9496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on each three-month anniversary measured from May 9, 2018 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 9, 2019 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":9496,"derivative":{"exercise_price":65.69,"expiration_date":"2028-05-09","underlying":"Common Stock","underlying_shares":9496},"source":{"system":"sec-edgar","filing":"0001127602-18-017238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218017238/form4.xml","form_type":"4"}},{"id":419842,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2018-02-02T21:12:03.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":480,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units will vest on January 31, 2019 at the end of the first year of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units will vest on January 31, 2019 at the end of the first year of service."}],"balance_after":480,"derivative":{"underlying":"Common Stock","underlying_shares":480},"source":{"system":"sec-edgar","filing":"0001127602-18-003636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218003636/form4.xml","form_type":"4"}},{"id":419841,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-02-02T21:12:03.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":2119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest quarterly over the first year of service and will be fully vested on January 31, 2019."}],"balance_after":2119,"derivative":{"exercise_price":83.8,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":2119},"source":{"system":"sec-edgar","filing":"0001127602-18-003636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218003636/form4.xml","form_type":"4"}},{"id":4219364,"issuer":{"id":97744,"kind":"organization","name":"DOW CHEMICAL CO /DE/"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-09-05T21:17:53.000Z","date":"2017-08-31","kind":"disposition_to_issuer","acquired":false,"shares":4638.237,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each phantom stock unit was the economic equivalent of one share of Common Stock of the Issuer. As a result of the Merger, the phantom stock units in respect of deferrals and associated earnings were automatically converted to the economic equivalent of one share of DowDuPont Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The phantom stock units were to be delivered entirely in cash in ten annual installments beginning in January following retirement. As a result of the Merger, these phantom stock units were assumed by DowDuPont and will be delivered according to the same terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The phantom stock units were to be delivered entirely in cash in ten annual installments beginning in January following retirement. As a result of the Merger, these phantom stock units were assumed by DowDuPont and will be delivered according to the same terms."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common","underlying_shares":4638.237},"source":{"system":"sec-edgar","filing":"0001225208-17-014609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/29915/000122520817014609/doc4.xml","form_type":"4"}},{"id":4219363,"issuer":{"id":97744,"kind":"organization","name":"DOW CHEMICAL CO /DE/"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common","published_at":"2017-09-05T21:17:53.000Z","date":"2017-08-31","kind":"disposition_to_issuer","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the \"Merger Agreement\"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., \"DowDuPont\"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont (\"DowDuPont Common Stock\"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the \"Merger Agreement\"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., \"DowDuPont\"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont (\"DowDuPont Common Stock\"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-17-014609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/29915/000122520817014609/doc4.xml","form_type":"4"}},{"id":4219362,"issuer":{"id":97744,"kind":"organization","name":"DOW CHEMICAL CO /DE/"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common","published_at":"2017-09-05T21:17:53.000Z","date":"2017-08-31","kind":"disposition_to_issuer","acquired":false,"shares":47475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the \"Merger Agreement\"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., \"DowDuPont\"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont (\"DowDuPont Common Stock\"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the \"Merger Agreement\"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., \"DowDuPont\"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont (\"DowDuPont Common Stock\"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-17-014609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/29915/000122520817014609/doc4.xml","form_type":"4"}},{"id":4320175,"issuer":{"id":97744,"kind":"organization","name":"DOW CHEMICAL CO /DE/"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common","published_at":"2017-05-16T19:15:37.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of stock with transfer restrictions exempt under Rule 16b-3"}],"balance_after":47475,"source":{"system":"sec-edgar","filing":"0001225208-17-009890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/29915/000122520817009890/doc4.xml","form_type":"4"}},{"id":4566302,"issuer":{"id":97744,"kind":"organization","name":"DOW CHEMICAL CO /DE/"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-11-07T21:09:08.000Z","date":"2016-11-03","kind":"exercise","acquired":false,"shares":6050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of stock with transfer restrictions under the 2003 Non-Employee Directors' Stock Incentive Plan in a transaction exempt under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":41.97,"exercise_date":"2008-03-05","expiration_date":"2017-03-05","underlying":"Common","underlying_shares":6050},"source":{"system":"sec-edgar","filing":"0001225208-16-041263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/29915/000122520816041263/doc4.xml","form_type":"4"}},{"id":4566301,"issuer":{"id":97744,"kind":"organization","name":"DOW CHEMICAL CO /DE/"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common","published_at":"2016-11-07T21:09:08.000Z","date":"2016-11-03","kind":"tax_withholding","acquired":false,"shares":4740,"price":53.58,"value":253969.2,"ownership":{"direct":true},"balance_after":44725,"source":{"system":"sec-edgar","filing":"0001225208-16-041263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/29915/000122520816041263/doc4.xml","form_type":"4"}},{"id":4566300,"issuer":{"id":97744,"kind":"organization","name":"DOW CHEMICAL CO /DE/"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true}}],"security":"Common","published_at":"2016-11-07T21:09:08.000Z","date":"2016-11-03","kind":"exercise","acquired":true,"shares":6050,"price":41.97,"value":253918.5,"ownership":{"direct":true},"balance_after":49465,"source":{"system":"sec-edgar","filing":"0001225208-16-041263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/29915/000122520816041263/doc4.xml","form_type":"4"}}]}